SEC SCHEDULE 13G

Company

Viridian Therapeutics, Inc.\DE

Filed

February 19, 2021

Accession Number

0001645257-21-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →